← Eichor
Condition: Treatment Resistant Schizophrenia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Treatment Resistant Schizophrenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of th
Phase 2/Phase 3 · 1 location(s) · SyneuRx International (Taiwan) Corp · NCT03094429Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.
NA · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06505668Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant
Phase 3 · 10 location(s) · Newron Pharmaceuticals SPA · NCT07184619Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
NA · 1 location(s) · Boston VA Research Institute, Inc. · NCT05299749Magnetic Seizure Therapy for Schizophrenia - Trial
NA · 2 location(s) · Centre for Addiction and Mental Health · NCT06672588Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
Phase 2 · 1 location(s) · China Medical University Hospital · NCT05240976Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia
NA · 1 location(s) · Dominique JANUEL · NCT06599372Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate
Phase 2 · 1 location(s) · National Cheng-Kung University Hospital · NCT06340789Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
NA · 14 location(s) · Central Institute of Mental Health, Mannheim · NCT06456983Acetazolamide for Treatment Resistant Schizophrenia
Phase 1/Phase 2 · 2 location(s) · Vishwajit Nimgaonkar, MD PhD · NCT04887792fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
NA · 1 location(s) · University Hospital, Lille · NCT04798131Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia
NA · 1 location(s) · Jimmi Nielsen · NCT06749444Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis
NA · 1 location(s) · Fundació Sant Joan de Déu · NCT07091344Deep Brain Stimulation for Psychosis
NA · 1 location(s) · Bradley Lega · NCT06257056Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation
NA · 1 location(s) · Centre Hospitalier St Anne · NCT06361160Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients
Phase N/A · 1 location(s) · University of Edinburgh · NCT07398365The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subje
Phase 4 · 13 location(s) · Dr. Inge Winter · NCT05958875Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.
Phase N/A · 1 location(s) · Health Service Executive, Ireland · NCT05074732SEEG-Guided DBS for Schizophrenia
NA · 1 location(s) · Ruijin Hospital · NCT07671261
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.